Self-complementary AAV Vectors; Advances and ApplicationsDouglas M. McCarty(Nationwide Children's Hospital)Molecular TherapyAugust 5, 200810.1038/mt.2008.171Cited by 496Open AccessFull TextSaveCiteExport RISWatch citationsAbstractRelated PapersTransduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesisKrishna J. Fisher, Guang Ping Gao, Matthew D. Weitzman et al.|Journal of Virology|1996|545Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2Elizabeth A. Rutledge, Christine L. Halbert, David W. Russell|Journal of Virology|1998|448Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virusDongsheng Duan, Yongping Yue, Ziying Yan et al.|Journal of Clinical Investigation|2000|388Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6Michael J. Blankinship, Paul Gregorevic, James M. Allen et al.|Molecular Therapy|2004|249DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectorsIan E. Alexander, David W. Russell, A. Dusty Miller|Journal of Virology|1994|225